Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

A dose of the Pfizer-BioNTech COVID-19 vaccine at a vaccination site in Vancouver on March 11, 2021.

JONATHAN HAYWARD/The Canadian Press

An infectious disease specialist says allowing people to choose which vaccine they receive could hurt public health efforts to contain COVID-19.

“In the interest of the greater good, if we all want to do our piece to end the pandemic as soon as possible, then it is in everyone’s interest to get the first vaccine that’s available to them that has shown to be safe in their setting,” said Dr. Ameeta Singh of the Royal Alexandra Hospital and University of Alberta in Edmonton.

“I already hear from friends and patients that they are deliberately making a decision to delay receiving the vaccine until they can receive a vaccine that they would prefer to have.”

Story continues below advertisement

Premier Jason Kenney was asked during a Facebook question-and-answer session earlier this week whether Albertans would be able to choose their shot.

So far, Canada has approved vaccines from Pfizer-BioNTech, Moderna, Oxford-AstraZeneca and Johnson & Johnson. The AstraZeneca vaccine is not being offered to Albertans over 65 as its efficacy in that age group remains in question.

Kenney, 52, said he expects he will be able to choose his vaccine when his turn comes.

He said some people have raised ethical concerns about the AstraZeneca shot because it was created using fetal stem cell lines. Some may also have preferences based on what they’ve learned about each vaccine’s efficacy.

“I’ve been clear with our health officials here that people must have a choice, partly to reflect their conscientious concerns that they might have on those ethical issues.”

The Canadian Conference on Catholic Bishops said in a note earlier this week that choosing to be vaccinated can be an “act of charity which recognizes the need to care for others.”

“Since there is currently no choice of vaccine being offered, Catholics in good conscience may receive the vaccine that is available and offered to them.”

Story continues below advertisement

But the bishops said, if given a choice, Catholics should opt for the vaccine least connected to abortion-derived cell lines. In Canada, that would mean picking the Moderna or Pfizer vaccines over AstraZeneca or J&J.

The province’s chief medical officer of health, Dr. Deena Hinshaw, said Albertans who are now eligible for the AstraZeneca vaccine can choose to get that shot or wait until a different one is available to them.

Health authorities have not worked out how people will be able to choose once there are multiple types of vaccines available, she added.

Singh said data from countries that have used all four of the vaccines that Canada has in its arsenal show each is effective in preventing serious illness, hospitalizations and deaths. The Pfizer and Moderna vaccines seem to be better at preventing mild illness.

“It shouldn’t be considered a big deal to get what is essentially a mild cold or upper respiratory tract infection,” she said. “Most of us have those every year and recover very well from them.”

Singh said Canadians are fortunate to have so many different vaccines at this stage.

Story continues below advertisement

“That’s actually a luxury and a privilege, which hasn’t been afforded, of course, to so many others.”

We have a weekly Western Canada newsletter written by our B.C. and Alberta bureau chiefs, providing a comprehensive package of the news you need to know about the region and its place in the issues facing Canada. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies